ContraFect Corp soars as Q1 loss narrows

CONTRAFECT

15/05/2023 17:40

** Shares of drug developer ContraFect Corporation  CFRX.O 
jump 21.3% to $1.82
    ** Co reports Q1 net loss of $1.4 mln, or 69 cents per
share, compared with a net loss of $20.2 mln, or $41.00 per
share, a year earlier
    ** CFRX had cash, cash equivalents and marketable securities
of $13.9 mln as of March 31, 2023
    ** Stock down 77.15% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))